Category: Health Policy - Page 2

January 9, 2026

How TRIPS Treaty Obligations Limit Access to Generic Medicines

The TRIPS agreement restricts generic medicine access in poor countries through strict patent rules. Despite flexibilities like compulsory licensing, political pressure and complex procedures have made them nearly impossible to use - leaving billions without affordable drugs.

December 30, 2025

Professional Liability and Generic Substitution: How Pharmacists Can Reduce Risk

Pharmacists face growing liability when substituting generic drugs, especially for narrow therapeutic index medications. Learn how state laws, federal preemption, and patient safety risks intersect-and what steps you can take to protect yourself today.

December 2, 2025

Affirmative Consent Laws: What They Really Mean for Medical Decision-Making

Affirmative consent laws apply to sexual activity, not medical care. Learn how real medical consent and substituted judgment work when patients can't decide for themselves - and why mixing the two can be dangerous.

November 16, 2025

How Patent Expiration Drives Drug Price Drops and Saves Billions

Patent expiration triggers massive drug price drops, often by 80% or more, as generics flood the market. Learn how this process works, why some drugs resist price cuts, and how patients can save thousands annually.

May 16, 2023

Udenafil and Public Policy: The Role of Government in Regulating and Promoting Its Use

In today's post, I'd like to discuss the importance of Udenafil and the role of government in regulating and promoting its use. Udenafil is a medication primarily used to treat erectile dysfunction and has shown great potential in improving the quality of life for many individuals. The government plays a crucial role in ensuring the safety and efficacy of this drug through regulation and proper guidelines. Additionally, it is essential for the government to promote the drug's benefits and accessibility to those in need. Overall, it is vital that the government takes an active role in both regulating and promoting the use of Udenafil to ensure the well-being of the public.